Quoin Pharmaceuticals, Ltd.
QNRX
$6.81
$0.213.18%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.31M | -2.35M | -1.97M | -2.33M | -2.05M |
| Total Depreciation and Amortization | 25.00K | 25.00K | 25.00K | 25.00K | 25.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 261.30K | 247.60K | 289.10K | 209.30K | 198.10K |
| Change in Net Operating Assets | -211.50K | -102.00K | -347.20K | 658.60K | -1.40M |
| Cash from Operations | -2.24M | -2.18M | -2.01M | -1.43M | -3.22M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.18M | 2.60M | 3.16M | -4.47M | 2.64M |
| Cash from Investing | -3.18M | 2.60M | 3.16M | -4.47M | 2.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -150.00K | -150.00K | -150.00K | -150.00K | -150.00K |
| Issuance of Common Stock | 6.07M | 100.00 | 13.70K | 5.48M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -32.60K |
| Cash from Financing | 5.92M | -149.90K | -136.30K | 5.33M | -182.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 506.60K | 271.60K | 1.01M | -567.70K | -762.20K |